Shanghai CirCode Biomed Co. Ltd.
PrivateLast Round
Series A
Aug 15, 2023
Company Overview
Shanghai CirCode Biomed Co. Ltd. operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series A round in August 2023.
Shanghai CirCode Biomed Co. Ltd. is a biotechnology company that develops circular RNA (circRNA) therapeutics for cardiovascular diseases, autoimmune disorders, and oncology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai CirCode Biomed Co. Ltd. Comparables
Compare Shanghai CirCode Biomed Co. Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Therorna Inc. | 89% | |
| RiboX Therapeutics | 85% | |
| Suzhou CureMed Biopharma Technology Co., Ltd. | 80% |
For institutional investors. Book with your work email.
Shanghai CirCode Biomed Co. Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 15, 2023 | ||||
| Pre Seed | Dec 16, 2021 | ||||
| Angel | Jun 29, 2021 |
For institutional investors. Book with your work email.
Shanghai CirCode Biomed Co. Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kaitai Capital | Pre Seed, Angel |
| Kunlun Capital | Pre Seed, Angel |
| 险峰K2VC | Pre Seed |
| Efung Capital | Pre Seed, Angel |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A |
| Apricot Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 15, 2023
Led by Johnson & Johnson Innovation.
- Dec 16, 2021
Led by K2VC with participation from Efung Capital, Kaitai Capital, and Kunlun Capital.
For institutional investors. Book with your work email.
Shanghai CirCode Biomed Co. Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shanghai CirCode Biomed Co. Ltd.'s valuation, stock price, and market status.
Is Shanghai CirCode Biomed Co. Ltd. a public or private company?
Shanghai CirCode Biomed Co. Ltd. is a private company.
What is the current stock price of Shanghai CirCode Biomed Co. Ltd.?
Shanghai CirCode Biomed Co. Ltd. is a private company, so its shares have no public market price. Caplight tracks Shanghai CirCode Biomed Co. Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shanghai CirCode Biomed Co. Ltd. worth (valuation)?
Valuation information for Shanghai CirCode Biomed Co. Ltd. is not publicly available.
Can I buy Shanghai CirCode Biomed Co. Ltd. stock?
Shanghai CirCode Biomed Co. Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shanghai CirCode Biomed Co. Ltd.'s last funding round?
Shanghai CirCode Biomed Co. Ltd.'s most recent funding round was Series A on August 15, 2023.
Who are the main investors in Shanghai CirCode Biomed Co. Ltd.?
Key investors in Shanghai CirCode Biomed Co. Ltd. include Kaitai Capital, 险峰K2VC, Johnson & Johnson Innovation - JJDC, Inc., Apricot Capital.
Will Shanghai CirCode Biomed Co. Ltd. IPO soon?
No public IPO plans have been announced for Shanghai CirCode Biomed Co. Ltd..
How can I track Shanghai CirCode Biomed Co. Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shanghai CirCode Biomed Co. Ltd.'s shares on secondary markets.